Van Geem SRL
The score of Van Geem shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +42 % Total assets +7 %
Accounts of the company itself (not consolidated).
The full file covers 9 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Van Geem's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 07 Jul 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 12 Jul 2024
- Year ended 31 Dec 2022filed on 23 Jun 2023
- Year ended 31 Dec 2021filed on 30 Jul 2022
Van Geem's financial analysis
- Solvency62.9%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Van Geem
Van Geem's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0825.544.729
- VAT number
- BE0825544729
- Peppol
- Registered · 0208:0825544729 · as of 01 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 May 2010
- Registered office
- 2018 Antwerp
- Latest accounts
- 2025 · filed on 07 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Van Geem (SRL) has been based in Antwerp since 2010, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 59,486 € and equity of 679,645 €; its revenue is not published. Its solvency stands at 62.9%, above the median of its sector (44.0%).
Companies similar to Van Geem
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Capavita Retail sale of pharmaceutical products Schoten · balance sheet €1.09m
- Apoteek Mommaert Retail sale of pharmaceutical products Beersel · balance sheet €1.09m
- Pharmadvance Retail sale of pharmaceutical products Chièvres · balance sheet €1.07m
- Novaka Pharma Retail sale of pharmaceutical products Nivelles · balance sheet €1.10m
- L.V.G. Pharma Retail sale of pharmaceutical products Puurs-Sint-Amands · balance sheet €1.06m
- Verhaeghe Pharma Retail sale of pharmaceutical products Izegem · balance sheet €1.05m
- Farma Noord Retail sale of pharmaceutical products Kalmthout · balance sheet €1.12m
Frequently asked questions about Van Geem
What is the revenue of Van Geem?
Van Geem files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Van Geem?
In Belgium, the VAT number is the company number prefixed with BE: BE0825544729 for Van Geem, if the company is VAT-registered. Its company number (CBE) is 0825.544.729.
Where is the registered office of Van Geem?
According to the CBE register, the registered office of Van Geem is in 2018 Antwerp.
What is the equity of Van Geem?
At the close of the 2025 financial year, the equity of Van Geem amounts to 679,645 €, a solvency of 62.9% of total assets.
Who manages Van Geem?
The register lists 2 active mandates at Van Geem. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Van Geem
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →